longum A 2025 randomized, double-blind, placebo-controlled trial reported that a Bifidobacterium breve strain significantly raised GLP-1 and fecal butyrate while improving insulin resistance in adults with obesity
Target Areas Cervical spine (C1C7) neck and arm symptoms Thoracic spine (T1T12) upper back pain The injection is designed to relieve inflammation around nerve roots
doi:10.1093/clinchem/42.3.416
Schedule: Weekly subcutaneous injections for 1216 weeks (or longer as appropriate)
Given the increasing interest in the GLP-1 target, we downloaded clinical trial data for ~3,800 GLP-1 related studies through July 2024 and asked, what other conditions are GLP-1 modulating drugs being tested for
PlexusDx medications come from licensed 503A compounding pharmacies and are prescribed only after medical evaluation, prioritizing your safety